Dr. Reddy’s shares spike after favourable generic drug ruling
Shares of Indian drugmaker Dr. Reddy’s Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell…
Zydus Cadila gets USFDA nod for generic cholesterol drug
New Delhi: Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to market cholesterol-lowering drug Atorvastatin Calcium tablets. The Ahmedabad-based group has received final…
Glenmark gets USFDA nod for pneumonia treatment drug
New Delhi: Glenmark Pharmaceuticals Thursday said it has received final approval from the US health regulator for Atovaquone, used for prevention and treatment of a type of pneumonia. Glenmark Pharmaceuticals…
Indoco Remedies gets two minor observations from USFDA for Goa plants
New Delhi: Drug firm Indoco Remedies Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants. The US Food and Drug Administration…
Strides board approves USD 15 mn investment in Stelis Biopharma
New Delhi: Strides Pharma Science Thursday said its board has approved plans to invest another USD 15 million in its biotech arm Stelis Biopharma. The company’s board has approved participation…
Monsanto appeals damning Roundup cancer verdict
San Francisco: Monsanto on Tuesday said it is asking an appeals court to toss out a damning verdict in a landmark Roundup weed-killer cancer trial and grant it another try.…
Piramal Enterprises plans to raise up to Rs 1,000 crore via NCDs
NEW DELHI: Piramal Enterprises Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on private placement basis. The administrative committee of…
Piramal Pharma Solutions announces completion of new lab facility
MUMBAI: Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore…
U.S. appeals court declines J&J bid to stop generic Zytiga sales
By Jan Wolfe A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for a temporary restraining order blocking sales of generic versions of its blockbuster prostate…
Roche-AbbVie cancer drug gets accelerated FDA approval
Roche Holding AG said on Wednesday its cancer drug, Venclexta, received accelerated approval from the U.S. Food and Drug Administration as part of a combination treatment for newly diagnosed patients…
